UNIGE document Scientific Article
previous document  unige:19962  next document
add to browser collection

Protein kinase C inhibitor, AEB-071, acts complementarily with cyclosporine to prevent islet rejection in rats

Merani, Shaheed
Pawlick, Rena L.
Edgar, Ryan L.
Emamaullee, Juliet
Anderson, Colin C.
Shapiro, A M James
Published in Transplantation. 2009, vol. 87, no. 1, p. 59-65
Abstract BACKGROUND: AEB-071 (AEB) is a specific inhibitor of protein kinase C, which prevents T-lymphocyte activation. The present study investigated the effect of AEB on rat islet allotransplantation alone or in combination with CTLA4-Ig, mycophenolate mofetil, or cyclosporine A (CsA). METHODS: A rodent allogeneic islet transplant model (Lewis to Wistar Furth) was used to investigate the efficacy of AEB as an immunosuppressive agent. Furthermore, the Lewis rat was used to screen for any AEB associated toxicities on glucose homeostasis in vivo. RESULTS: AEB alone (30 mg/kg per os [p.o.] two times per day [bid]) delayed rejection to a median survival time of 22 days (vs. 7 days in control vehicle-treated animals, P<0.05). When combined with CsA (5 mg/kg p.o. bid), AEB prolonged survival from 12 (CsA alone) to over 100 days in 80% of animals (P<0.05). No delay in allograft rejection (above that resulting from AEB alone) was observed when AEB was combined with a sub-therapeutic dose of CTLA4-Ig or mycophenolate mofetil, nor low dose of CsA. The frequency of allospecific interferon-gamma-secreting splenocytes, assessed ex vivo by enzyme-linked immunosorbent spot (ELISPOT) assay, was lower in AEB-treated recipients compared with controls (P<0.05). AEB treatment did not alter the intraperitoneal glucose tolerance, the glucose-dependent insulin release, or the insulin content of the native pancreas. CONCLUSIONS: These data suggest that AEB is an appropriate immunosuppressive agent for islet transplantation, as it can prolong islet graft survival alone or in combination with CsA, without toxicity on glucose metabolism.
Keywords AnimalsAutoimmunity/immunologyCD4-Positive T-Lymphocytes/drug effects/immunologyCD8-Positive T-Lymphocytes/drug effects/immunologyCyclosporine/pharmacologyDrug SynergismFemaleGraft Rejection/immunology/metabolism/*prevention & controlImmunosuppressive Agents/*pharmacologyInsulin/metabolismIslets of Langerhans/physiology*Islets of Langerhans TransplantationMaleProtein Kinase C/*antagonists & inhibitors/metabolismProtein Kinase Inhibitors/*pharmacologyRatsTime FactorsTransplantation, Homologous
PMID: 19136892
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
Research group Transplantation et hépatologie (905)
(ISO format)
MERANI, Shaheed et al. Protein kinase C inhibitor, AEB-071, acts complementarily with cyclosporine to prevent islet rejection in rats. In: Transplantation, 2009, vol. 87, n° 1, p. 59-65. doi: 10.1097/TP.0b013e31819198b4 https://archive-ouverte.unige.ch/unige:19962

368 hits

0 download


Deposited on : 2012-04-23

Export document
Format :
Citation style :